Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 CAD | -.--% | -.--% | -.--% |
Oct. 27 | Lumiera Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2023 | CI |
Oct. 04 | Lumiera Health Inc. Appoints Mr. Shawn Moniz to the Board of Directors | CI |
Sales 2021 | 538K 397K | Sales 2022 | 631K 466K | Capitalization | 850K 628K |
---|---|---|---|---|---|
Net income 2021 | -1M -738K | Net income 2022 | -2M -1.48M | EV / Sales 2021 | 5.51 x |
Net Debt 2021 | 416K 308K | Net Debt 2022 | 1.88M 1.39M | EV / Sales 2022 | 4.33 x |
P/E ratio 2021 |
-1.52
x | P/E ratio 2022 |
-0.31
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 62.87% |
Managers | Title | Age | Since |
---|---|---|---|
Louis Doyle
DFI | Director of Finance/CFO | 66 | 21-11-17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kevin Cole
CHM | Chairman | - | 20-08-31 |
Director/Board Member | - | 22-02-21 | |
Louis Doyle
DFI | Director of Finance/CFO | 66 | 21-11-17 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 628K | |
+33.46% | 701B | |
+26.24% | 570B | |
+0.93% | 381B | |
+21.03% | 334B | |
+17.51% | 322B | |
+2.95% | 212B | |
+0.74% | 209B | |
-6.05% | 205B | |
-3.61% | 157B |